Cancer Institute Clinical Trials - Gynecologic

Ovarian

#90627 NCT00951496
Title: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in treating patients with Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Study Location: Temple Main Campus


For more information or to enroll in a study please call: 1-254-724-5407


Print
Text Size
A
A
A